Close menu



Durvalumab-like - Labelled (Arg,Lys) 13C15N


Quantification of Durvalumab

Specific labelling

Arginine: 13C6,15N4>99%

Lysine: 13C6,15N2, >99%


Labelled Durvalumab-like is a recombinant, stable isotope labelledmonoclonal IgG1-Kappa antibody containing proteotypic peptidesderived from Durvalumab’s originator sequence. LabelledDurvalumab-like is designed for use as an internal standard forquantitative analysis of Durvalumab in plasma samples. Durvalumabtargets the immune checkpoint programmed death-ligand 1 (PD-L1)and is used to treat a number of cancers

This product is for research use only and is not intended for diagnostic or therapeutic use.